share_log

Arbe Robotics (NASDAQ:ARBE) Versus IDEX Biometrics ASA (NASDAQ:IDBA) Financial Review

Arbe Robotics (NASDAQ:ARBE) Versus IDEX Biometrics ASA (NASDAQ:IDBA) Financial Review

Arbe Robotics(納斯達克股票代碼:ARBE)對比 IDEX Biometrics ASA(納斯達克股票代碼:IDBA)金融評論
Defense World ·  2023/04/10 02:32

Arbe Robotics (NASDAQ:ARBE – Get Rating) and IDEX Biometrics ASA (NASDAQ:IDBA – Get Rating) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, dividends, valuation and profitability.

Arbe Robotics(納斯達克股票代碼:ARBE — 獲取評級)和IDEX Biometrics ASA(納斯達克股票代碼:IDBA — 獲取評級)都是小型企業服務公司,但哪家業務更好?我們將根據兩家公司的收益、機構所有權、風險、分析師建議、股息、估值和盈利能力對比這兩家公司。

Risk and Volatility

風險和波動性

Arbe Robotics has a beta of -0.73, suggesting that its share price is 173% less volatile than the S&P 500. Comparatively, IDEX Biometrics ASA has a beta of 1.99, suggesting that its share price is 99% more volatile than the S&P 500.

Arbe Robotics的beta值爲-0.73,這表明其股價的波動性比標準普爾500指數低173%。相比之下,IDEX Biometrics ASA的beta值爲1.99,這表明其股價的波動性比標準普爾500指數高99%。

Get
獲取
Arbe Robotics
Arbe 機器人
alerts:
警報:

Profitability

盈利能力

This table compares Arbe Robotics and IDEX Biometrics ASA's net margins, return on equity and return on assets.

該表比較了Arbe Robotics和IDEX Biometrics ASA的淨利潤率、股本回報率和資產回報率。

Net Margins Return on Equity Return on Assets
Arbe Robotics -1,151.35% -74.78% -60.66%
IDEX Biometrics ASA -819.01% -142.69% -120.97%
淨利潤 股本回報率 資產回報率
Arbe 機器人 -1,151.35% -74.78% -60.66%
IDEX 生物識別 ASA -819.01% -142.69% -120.97%

Institutional & Insider Ownership

機構所有權和內部所有權

7.5% of Arbe Robotics shares are held by institutional investors. Comparatively, 0.0% of IDEX Biometrics ASA shares are held by institutional investors. 53.5% of Arbe Robotics shares are held by company insiders. Comparatively, 1.8% of IDEX Biometrics ASA shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Arbe Robotics7.5%的股份由機構投資者持有。相比之下,IDEX Biometrics ASA中有0.0%的股票由機構投資者持有。53.5%的Arbe Robotics股份由公司內部人士持有。相比之下,IDEX Biometrics ASA的1.8%股票由公司內部人士持有。強大的機構所有權表明,捐贈基金、對沖基金和大型基金經理認爲,從長遠來看,股票的表現將超過市場。

Earnings and Valuation

收益和估值

This table compares Arbe Robotics and IDEX Biometrics ASA's gross revenue, earnings per share and valuation.

該表比較了Arbe Robotics和IDEX Biometrics ASA的總收入、每股收益和估值。

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Arbe Robotics $3.52 million 54.35 -$40.49 million ($0.71) -4.15
IDEX Biometrics ASA $4.09 million 26.64 -$32.66 million ($2.09) -3.34
總收入 價格/銷售比率 淨收入 每股收益 市盈率
Arbe 機器人 352 萬美元 54.35 -4,049 萬美元 (0.71 美元) -4.15
IDEX 生物識別 ASA 409 萬美元 26.64 -3266 萬美元 (2.09 美元) -3.34

IDEX Biometrics ASA has higher revenue and earnings than Arbe Robotics. Arbe Robotics is trading at a lower price-to-earnings ratio than IDEX Biometrics ASA, indicating that it is currently the more affordable of the two stocks.

IDEX Biometrics ASA的收入和收益高於Arbe Robotics。Arbe Robotics的市盈率低於IDEX Biometrics ASA,這表明它目前是這兩隻股票中更實惠的一隻。

Analyst Ratings

分析師評級

This is a breakdown of current ratings and price targets for Arbe Robotics and IDEX Biometrics ASA, as reported by MarketBeat.com.

據Marketbeat.com報道,這是Arbe Robotics和IDEX Biometrics ASA當前評級和目標價格的明細。

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Arbe Robotics 0 0 0 0 N/A
IDEX Biometrics ASA 0 0 0 0 N/A
賣出評級 保持收視率 買入評級 強勁的買入評級 評分分數
Arbe 機器人 0 0 0 0 不適用
IDEX 生物識別 ASA 0 0 0 0 不適用

Arbe Robotics presently has a consensus target price of $9.00, indicating a potential upside of 205.08%. Given Arbe Robotics' higher possible upside, research analysts plainly believe Arbe Robotics is more favorable than IDEX Biometrics ASA.

Arbe Robotics目前的共識目標價爲9.00美元,表明潛在的上漲空間爲205.08%。鑑於Arbe Robotics可能有更高的上行空間,研究分析師顯然認爲Arbe Robotics比IDEX Biometrics ASA更有利。

Summary

摘要

Arbe Robotics beats IDEX Biometrics ASA on 7 of the 12 factors compared between the two stocks.

在比較兩隻股票的12個因素中,Arbe Robotics在7個因素上擊敗了IDEX Biometrics ASA。

About Arbe Robotics

關於 Arbe 機器人

(Get Rating)

(獲取評分)

Arbe Robotics Ltd., a semiconductor company, provides 4D imaging radar solutions for tier 1 automotive suppliers and automotive manufacturers in Israel and the United States. It offers 4D imaging radar chipset solutions that address the core issues that have caused autonomous vehicle and autopilot accidents, such as detecting stationary objects, identifying vulnerable road users, and eliminating false alarms without radar ambiguities. The company was founded in 2015 and is headquartered in Tel Aviv-Yafo, Israel.

Arbe Robotics Ltd. 是一家半導體公司,爲以色列和美國的一級汽車供應商和汽車製造商提供四維成像雷達解決方案。它提供四維成像雷達芯片組解決方案,可解決導致自動駕駛車輛和自動駕駛事故的核心問題,例如檢測靜止物體、識別弱勢道路使用者以及在不產生雷達歧義的情況下消除虛假警報。該公司成立於2015年,總部位於以色列特拉維夫-雅法。

About IDEX Biometrics ASA

關於 IDEX 生物識別 ASA

(Get Rating)

(獲取評分)

IDEX Biometrics ASA engages in the design, development, and sale of fingerprint authentication solutions in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's fingerprint authentication solutions are used primarily in contactless financial payment, access control, and smart cards, as well as card-based devices for the storage of digital currencies. It primarily serves manufacturers of smart cards for financial payment applications and biometric payment card markets. IDEX Biometrics ASA was incorporated in 1996 and is headquartered in Oslo, Norway.

IDEX Biometrics ASA在歐洲、中東、非洲、美洲和亞太地區從事指紋認證解決方案的設計、開發和銷售。該公司的指紋認證解決方案主要用於非接觸式金融支付、訪問控制和智能卡,以及用於存儲數字貨幣的基於卡的設備。它主要爲金融支付應用和生物識別支付卡市場的智能卡製造商提供服務。IDEX Biometrics ASA 成立於 1996 年,總部位於挪威奧斯陸。

Receive News & Ratings for Arbe Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arbe Robotics and related companies with MarketBeat.com's FREE daily email newsletter.

接收 Arbe Robots每日的新聞和評級 -在下面輸入您的電子郵件地址,即可通過Marketbeat.com的免費每日電子郵件時事通訊接收Arbe Robotics及相關公司的最新新聞和分析師評級的簡明每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論